FR2527447A1 - Procede d'amelioration metabolique par autohemostimulation potentialisee - Google Patents
Procede d'amelioration metabolique par autohemostimulation potentialisee Download PDFInfo
- Publication number
- FR2527447A1 FR2527447A1 FR8209295A FR8209295A FR2527447A1 FR 2527447 A1 FR2527447 A1 FR 2527447A1 FR 8209295 A FR8209295 A FR 8209295A FR 8209295 A FR8209295 A FR 8209295A FR 2527447 A1 FR2527447 A1 FR 2527447A1
- Authority
- FR
- France
- Prior art keywords
- blood
- vaccine
- compsn
- injected
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 10
- 239000008280 blood Substances 0.000 title claims abstract description 10
- 229960005486 vaccine Drugs 0.000 title claims abstract description 9
- 238000007918 intramuscular administration Methods 0.000 title claims 2
- 241001465754 Metazoa Species 0.000 title abstract description 8
- 230000004936 stimulating effect Effects 0.000 title 1
- 230000006872 improvement Effects 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000017363 positive regulation of growth Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 241000282326 Felis catus Species 0.000 abstract description 2
- 230000000941 anti-staphylcoccal effect Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000036314 physical performance Effects 0.000 description 2
- 206010056720 Muscle mass Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8209295A FR2527447A1 (fr) | 1982-05-27 | 1982-05-27 | Procede d'amelioration metabolique par autohemostimulation potentialisee |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8209295A FR2527447A1 (fr) | 1982-05-27 | 1982-05-27 | Procede d'amelioration metabolique par autohemostimulation potentialisee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2527447A1 true FR2527447A1 (fr) | 1983-12-02 |
| FR2527447B1 FR2527447B1 (enExample) | 1985-03-29 |
Family
ID=9274414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8209295A Granted FR2527447A1 (fr) | 1982-05-27 | 1982-05-27 | Procede d'amelioration metabolique par autohemostimulation potentialisee |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2527447A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003409A1 (fr) * | 1984-12-04 | 1986-06-19 | Leguern Jacques Andre | Procede d'amelioration metabolique par autohemostimulation pontentialisee |
| FR2581313A1 (fr) * | 1985-05-02 | 1986-11-07 | Pasteur Institut | Composes suscitant la formation d'anticorps, compositions immunogeniques et compositions immunoprotectrices les contenant et procede d'obtention d'anticorps les mettant en oeuvre |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2009493A1 (enExample) * | 1968-05-28 | 1970-02-06 | Merieux Inst |
-
1982
- 1982-05-27 FR FR8209295A patent/FR2527447A1/fr active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2009493A1 (enExample) * | 1968-05-28 | 1970-02-06 | Merieux Inst |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986003409A1 (fr) * | 1984-12-04 | 1986-06-19 | Leguern Jacques Andre | Procede d'amelioration metabolique par autohemostimulation pontentialisee |
| FR2581313A1 (fr) * | 1985-05-02 | 1986-11-07 | Pasteur Institut | Composes suscitant la formation d'anticorps, compositions immunogeniques et compositions immunoprotectrices les contenant et procede d'obtention d'anticorps les mettant en oeuvre |
| EP0201413A1 (fr) * | 1985-05-02 | 1986-12-17 | INSTITUT PASTEUR Fondation reconnue d'utilité publique | Composés suscitant la formation d'anticorps, compositions immunogéniques et compositions immunoprotectrices les contenant et procédé d'obtention d'anticorps les mettant en oeuvre |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2527447B1 (enExample) | 1985-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stěhulová et al. | Response of dairy cows and calves to early separation: Effect of calf age and visual and auditory contact after separation | |
| Slocombe | Prevalence and treatment of tapeworms in horses | |
| CN110447778B (zh) | 过瘤胃褪黑素在改善反刍动物瘤胃微生物菌群结构和提高乳品质中的应用 | |
| Ning et al. | Effects of continuous low dose infusion of lipopolysaccharide on inflammatory responses, milk production and milk quality in dairy cows | |
| Pietrzak-Fiećko et al. | Effect of mare’s breed on the fatty acid composition of milk fat | |
| FR2527447A1 (fr) | Procede d'amelioration metabolique par autohemostimulation potentialisee | |
| WO1986003409A1 (fr) | Procede d'amelioration metabolique par autohemostimulation pontentialisee | |
| Fredriksson et al. | Endotoxin-induced and prostaglandin-mediated effects on corpus luteum function in the mare | |
| RU2011137856A (ru) | Иммуномодуляторные терапевтические агенты | |
| CN112370421A (zh) | 一种改善乳品质的组合物及其制备方法和应用 | |
| Zygoyiannis | A note on the effect of number and genotype of kids on milk yield and composition of indigenous Greek goats (Capra prisca) | |
| RU2416430C1 (ru) | Средство для профилактики гепатоза у свиней | |
| FR3008318A1 (fr) | Produit de sante canin | |
| CN120641086A (zh) | 用于改善禽畜的繁殖能力的组合物 | |
| EP1781115B1 (fr) | Complement alimentaire pour animaux d'elevage | |
| WO2021013951A1 (en) | Veterinary compositions comprising melatonin and their uses for ruminants | |
| US6022563A (en) | Phenylbutazone carrier formulation | |
| RU2601156C2 (ru) | Способ увеличения выхода спермопродукции у быков - производителей | |
| Grega et al. | The presence of thyroxine in bovine precolostrum and colostrum | |
| SU854355A1 (ru) | Способ повышени молочной продуктивности животных | |
| Lykhach et al. | Influence of enrichment materials on the behaviour and productive traits of fattening pigs | |
| JP4943624B2 (ja) | 訓練誘導徐脈を向上させるためのカルニチンの使用 | |
| Nisrina et al. | The Effect of Vitamin C Administration on Hemoglobin and Hematocrit of Albino Rats (Rattus norvegicus) Ratna Damayanti1*, Hasna Firdhausia1, Deninda Ainaya1, Khansa Kha1, Naila | |
| RU2718748C1 (ru) | Способ коррекции метаболизма при риске развития жирового гепатоза у лактирующих коров | |
| US20110021591A1 (en) | Phenylbutazone carrier formulation showing increased bioactivity in animals |